Pet drug maker Dechra Pharma raises £134m in placing

Dechra Pharmacuticals, the pharmaceutical company focused on pets, raised £134m in an accelerated placing on Wednesday night to strengthen its balance sheet after an M&A wave and to give it headroom for further growth and to protect against the economic headwinds of the coronavirus pandemic.